This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Członkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, et al. Wilson disease. Nat Rev Dis Prim. 2018; 4(1): 21.CzłonkowskaALitwinTDusekPFerenciPLutsenkoSMediciVet alWilson disease2018412110.1016/B978-0-444-63625-6.00010-028433096Search in Google Scholar
Ala A, Schilsky M. Genetic modifiers of liver injury in hereditary liver disease. Semin Liver Dis. 2011; 31(2): 208-214.AlaASchilskyMGenetic modifiers of liver injury in hereditary liver disease201131220821410.1055/s-0031-127664821538285Search in Google Scholar
Medici V, Weiss K-H. Genetic and environmental modifiers of Wilson disease. In: Członkowska A, Schilsky ML, Editors. Handbook of Clinical Neurology. Amsterdam, The Netherlands: Elsevier. 2017; 142: 35-41.MediciVWeissK-HGenetic and environmental modifiers of Wilson diseaseCzłonkowskaASchilskyMLEditorsAmsterdam, The NetherlandsElsevier2017142354110.1016/B978-0-444-63625-6.00004-5Search in Google Scholar
Kluska A, Kulecka M, Litwin T, Dziezyc K, Balabas A, Piatkowska M, et al. Whole-exome sequencing identifies novel pathogenic variants across the ATP7B gene and some modifiers of Wilson’s disease phenotype. Liver Int. 2019; 39(1): 177-186.KluskaAKuleckaMLitwinTDziezycKBalabasAPiatkowskaMet alWhole-exome sequencing identifies novel pathogenic variants across the ATP7B gene and some modifiers of Wilson’s disease phenotype201939117718610.1111/liv.1396730230192Search in Google Scholar
Simon I, Schaefer M, Reichert J, Stremmel W. Analysis of the human Atox 1 homologue in Wilson patients. World J Gastroenterol. 2008; 14(15): 2383-2387.SimonISchaeferMReichertJStremmelWAnalysis of the human Atox 1 homologue in Wilson patients200814152383238710.3748/wjg.14.2383270509418416466Search in Google Scholar
Gupta A, Chattopadhyay I, Mukherjee S, Sengupta M, Das SK, Ray K. A novel COMMD1 mutation Thr174 Met associated with elevated urinary copper and signs of enhanced apoptotic cell death in a Wilson Disease patient. Behav Brain Funct. 2010; 6: 33.GuptaAChattopadhyayIMukherjeeSSenguptaMDasSKRayKA novel COMMD1 mutation Thr174 Met associated with elevated urinary copper and signs of enhanced apoptotic cell death in a Wilson Disease patient201063310.1186/1744-9081-6-33289633820550661Search in Google Scholar
Patel BN, Dunn RJ, Jeong SY, Zhu Q, Julien J-P, David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci. 2002; 22(15): 6578-6586.PatelBNDunnRJJeongSYZhuQJulienJ-PDavidSCeruloplasmin regulates iron levels in the CNS and prevents free radical injury200222156578658610.1523/JNEUROSCI.22-15-06578.2002Search in Google Scholar
Zhao N, Xiao J, Zheng Z, Fei G, Zhang F, Jin L, et al. Single-nucleotide polymorphisms and haplotypes of non-coding area in the CP gene are correlated with Parkinson’s disease. Neurosci Bull. 2015; 31(2); 245-256.ZhaoNXiaoJZhengZFeiGZhangFJinLet alSingle-nucleotide polymorphisms and haplotypes of non-coding area in the CP gene are correlated with Parkinson’s disease201531224525610.1007/s12264-014-1512-6556370425758665Search in Google Scholar
Adamsson Eryd S, Sjögren M, Smith JG, Nilsson PM, Melander O, Hedblad B, et al. Ceruloplasmin and atrial fibrillation: Evidence of causality from a population-based Mendelian randomization study. J Intern Med. 2014; 275(2): 164-171.Adamsson ErydSSjögrenMSmithJGNilssonPMMelanderOHedbladBet alCeruloplasmin and atrial fibrillation: Evidence of causality from a population-based Mendelian randomization study2014275216417110.1111/joim.1214424118451Search in Google Scholar
Arenas de Larriva AP, Norby FL, Chen LY, Soliman EZ, Hoogeveen RC, Arking DE, et al. Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study. Int J Cardiol. 2017; 241: 223-228.Arenas de LarrivaAPNorbyFLChenLYSolimanEZHoogeveenRCArkingDEet alCirculating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study201724122322810.1016/j.ijcard.2017.04.005551566928427851Search in Google Scholar
Ferenci P, Czlonkowska A, Stremmel W, Houwen R, Rosenberg W, Schilsky M, et al.; EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol. 2012; 56(3): 671-685. 2012.FerenciPCzlonkowskaAStremmelWHouwenRRosenbergWSchilskyMet al.;EASL Clinical Practice Guidelines: Wilson’s disease2012563671685201210.1016/j.jhep.2011.11.00722340672Search in Google Scholar
Gromadzka G, Schmidt HHJ, Genschel J, Bochow B, Rodo M, Tamacka B, et al. Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson’s disease. Clin Genet. 2005; 68(6): 524-532.GromadzkaGSchmidtHHJGenschelJBochowBRodoMTamackaBet alFrameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson’s disease200568652453210.1111/j.1399-0004.2005.00528.x16283883Search in Google Scholar
Poláková H, Katrincsáková B, Minárik G, Ferakova, E, Ficek A, Baldovic M, et al. Detection of His-1069Gln mutation in Wilson disease by bidirectional PCR amplification of specific alleles (BI-PASA) test. Gen Physiol Biophys. 2007; 26(2): 91-96.PolákováHKatrincsákováBMinárikGFerakovaEFicekABaldovicMet alDetection of His-1069Gln mutation in Wilson disease by bidirectional PCR amplification of specific alleles (BI-PASA) test20072629196Search in Google Scholar
Krumina A, Keiss J, Sondore V, Chernushenko A, Cernevska G, Zarina A, et al. From clinical and biochemical to molecular genetic diagnosis of Wilson disease in Latvia. Genetika. 2008; 44(10): 1379-1384.KruminaAKeissJSondoreVChernushenkoACernevskaGZarinaAet alFrom clinical and biochemical to molecular genetic diagnosis of Wilson disease in Latvia200844101379138410.1134/S1022795408100086Search in Google Scholar
Zarina A, Tolmane I, Kreile M, Chernushenko A, Cernevska G, Pukite I, et al. Genetic variation spectrum in ATP7B gene identified in Latvian patients with Wilson disease. Mol Genet Genomic Med. 2017; 5(4): 405-409.ZarinaATolmaneIKreileMChernushenkoACernevskaGPukiteIet alGenetic variation spectrum in ATP7B gene identified in Latvian patients with Wilson disease20175440540910.1002/mgg3.297551179728717664Search in Google Scholar
gnomAD. [Online]. Available: https://gnomad.broadinstitute.org/. [Accessed: April 15 2019].[Online]. Availablehttps://gnomad.broadinstitute.org/Accessed: April 152019Search in Google Scholar
Chr13: 52.51M-52.51M, 1000 Genomes Browser. [Online]. Available: https://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/?gts=rs1057516740 [Accessed: October 16 2018].[Online]. Availablehttps://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/?gts=rs1057516740Accessed: October 16 2018Search in Google Scholar
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5): 405-424.RichardsSAzizNBaleSBickDDasSGastier-FosterJet alStandards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology201517540542410.1038/gim.2015.30454475325741868Search in Google Scholar
Human Splicing Finder, Version 3.1. [Online]. Available: http://www.umd.be/HSF3/. [Accessed: October 18 2018].[Online]. Availablehttp://www.umd.be/HSF3/Accessed: October 182018Search in Google Scholar
Hedera P. Update on the clinical management of Wilson’s disease. Appl Clin Genet. 2017; 10: 9-19.HederaPUpdate on the clinical management of Wilson’s disease20171091910.2147/TACG.S79121524591628144156Search in Google Scholar
Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: An update. Hepatology. 2008; 47(6): 2089-2111.RobertsEASchilskyMLDiagnosis and treatment of Wilson disease: An update20084762089211110.1002/hep.2226118506894Search in Google Scholar
Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr. 2002; 22(1): 439-458.HellmanNEGitlinJDCeruloplasmin metabolism and function200222143945810.1146/annurev.nutr.22.012502.11445712055353Search in Google Scholar
van De Sluis B, Rothuizen J, Pearson PL, van Oost BA, Wijmenga C. Identification of a new copper metabolism gene by positional cloning in a purebred dog population. Hum Mol Genet. 2002; 11(2): 165-173.van De SluisBRothuizenJPearsonPLvan OostBAWijmengaCIdentification of a new copper metabolism gene by positional cloning in a purebred dog population200211216517310.1093/hmg/11.2.16511809725Search in Google Scholar
Stuehler B, Reichert J, Stremmel W, Schaefer M. Analysis of the human homologue of the canine copper toxicosis gene MURR1 in Wilson disease patients. J Mol Med. 2004; 82(9): 629-634.StuehlerBReichertJStremmelWSchaeferMAnalysis of the human homologue of the canine copper toxicosis gene MURR1 in Wilson disease patients200482962963410.1007/s00109-004-0557-915205742Search in Google Scholar
Lovicu M, Dessi V, Lepori MB, Zappu A, Zancan L, Giacchino R, et al.. The canine copper toxicosis gene MURR1 is not implicated in the pathogenesis of Wilson disease. J Gastroenterol. 2006; 41(6): 582-587.LovicuMDessiVLeporiMBZappuAZancanLGiacchinoRet alThe canine copper toxicosis gene MURR1 is not implicated in the pathogenesis of Wilson disease200641658258710.1007/s00535-006-1807-016868807Search in Google Scholar
Weiss KH, Merle U, Schaefer M, Ferenci P, Fullekrug J, Stremmel W. Copper toxicosis gene MURR1 is not changed in Wilson disease patients with normal blood ceruloplasmin levels. World J Gastroenterol. 2006; 12(14): 2239-2242.WeissKHMerleUSchaeferMFerenciPFullekrugJStremmelWCopper toxicosis gene MURR1 is not changed in Wilson disease patients with normal blood ceruloplasmin levels200612142239224210.3748/wjg.v12.i14.2239408765316610028Search in Google Scholar